Investor relations Header image

SEC Filing Details

SEC Filing Details

Document Details

Form
4
Filing Date
January 10, 2023
Document Date
January 8, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Kezar Life Sciences, Inc.
Issuer
Kezar Life Sciences, Inc.
Filer
Fowler John Franklin